Article
Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.
Diagnostic microbiology and infectious disease - 1 Apr 2018
Choi Hayoung, Jhun Byung Woo, Kim Su-Young, Kim Dae Hun, Lee Hyun, Jeon Kyeongman, Kwon O Jung, Huh Hee Jae, Ki Chang-Seok, Lee Nam Yong, Shin Sung Jae, Daley Charles L, Koh Won-Jung
Abstract excerpt
Mycobacterium abscessus lung disease is difficult to treat due to inducible resistance to macrolides. However, 15%-20% of isolates are macrolide susceptible. In 14 patients with macrolide-susceptible M. abscessus lung disease, all isolates had nonfunctional erm(41) gene, and sputum culture conversion rate was achieved in 93% (13/14) following antibiotic therapy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
